Lopinavir And Ritonavir
NDC Package 68071-2949-2

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings
Table of Contents
    1. Package Information
    2. Frequently Asked Questions

Package Information

This product is EXCLUDED from the official NDC directory because the listing data was inactivated by the FDA.

Lopinavir And Ritonavir is indicated in combination with other antiretroviral agents for the treatment of HIV- 1 infection in adults and pediatric patients 14 days and older.Limitations of Use:Genotypic or phenotypic testing and/or treatment history should guide the use of  lopinavir and ritonavir. Marketed by Nucare Pharmaceuticals,inc., this product is identified by NDC 68071-2949 and is authorized under FDA application ANDA213857.

Identification & Billing

NDC Package Code
68071-2949-2
Package Description
12 TABLET, FILM COATED in 1 BOTTLE
Product Code
68071-2949
11-Digit Billing Format
68071294902
RxNorm Crosswalk
RxCUI: 597730 - lopinavir 200 MG / ritonavir 50 MG Oral Tablet

Clinical Specifications

Proprietary Name
Lopinavir And Ritonavir
Dosage Form
-
Usage Information
Lopinavir and ritonavir is indicated in combination with other antiretroviral agents for the treatment of HIV- 1 infection in adults and pediatric patients 14 days and older.Limitations of Use:Genotypic or phenotypic testing and/or treatment history should guide the use of  lopinavir and ritonavir. The number of baseline lopinavir resistance-associated substitutions affects the virologic response to lopinavir and ritonavir [ see Microbiology (12.4)] .

Regulatory & Marketing

Labeler Name
Nucare Pharmaceuticals,inc.
FDA Application #
ANDA213857
Marketing Category
ANDA - A product marketed under an approved Abbreviated New Drug Application.
Start Marketing Date
03-21-2022
Listing Expiration
12-31-2024
Exclude Flag
I
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 68071-2949-2 identifies a specific commercial package of 12 tablet, film coated in 1 bottle of Lopinavir And Ritonavir, labeled by Nucare Pharmaceuticals,inc.. This is formulated for use and contains as the active substance.

Is this product currently listed with the FDA?

This product code is currently listed as inactive or excluded from the primary directory. It was introduced to the market by Nucare Pharmaceuticals,inc. on March 21, 2022. The current certification is valid through December 31, 2024.

How is this Nucare Pharmaceuticals,inc. product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 68071294902. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-4-1)
68071-2949-2
11-Digit CMS (5-4-2)
68071-2949-02

Note: The zero is added to the Package segment to maintain the 5-4-2 structure.